Company LivaNova PLC

Equities

LIVN

GB00BYMT0J19

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
52.33 USD -0.82% Intraday chart for LivaNova PLC -1.25% +1.14%

Business Summary

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Number of employees: 2,900

Sales per Business

USD in Million2022Weight2023Weight Delta
Cardiopulmonary
51.1 %
500 49.0 % 589 51.1 % +17.72%
Neuromodulation
45.1 %
477 46.7 % 520 45.1 % +8.96%
Advanced Circulatory Support
3.5 %
39 3.8 % 40 3.5 % +2.60%
Other
0.4 %
5 0.5 % 5 0.4 % -12.72%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
55.1 %
572 55.9 % 635 55.1 % +11.11%
Rest of World
26.3 %
271 26.6 % 304 26.3 % +11.89%
Europe
15.0 %
147 14.3 % 173 15.0 % +18.29%
United Kingdom
3.6 %
32 3.2 % 42 3.6 % +28.48%

Managers

Managers TitleAgeSince
Chairman 72 18-06-11
Director of Finance/CFO 54 16-12-31
Chief Tech/Sci/R&D Officer - 18-01-07
Investor Relations Contact - 22-07-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Human Resources Officer 52 19-03-17
General Counsel 53 22-10-31
Corporate Officer/Principal 57 14-12-31
Corporate Officer/Principal - 21-02-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 20-12-02
Director/Board Member 64 22-06-12
Chairman 72 18-06-11
Director/Board Member 60 19-06-17
Director/Board Member 56 15-10-18
Director/Board Member 63 15-08-31
Director/Board Member 66 15-10-18
Director/Board Member 52 23-10-05
Director/Board Member 52 22-09-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,980,087 53,677,594 ( 99.44 %) 23,929 ( 0.0443 %) 99.44 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
12.91 %
6,965,860 12.91 % 390 M $
PRIMECAP Management Co.
10.73 %
5,791,280 10.73 % 324 M $
Millennium Management LLC
5.066 %
2,733,440 5.066 % 153 M $
Barrow, Hanley, Mewhinney & Strauss LLC
4.396 %
2,372,027 4.396 % 133 M $
Millennium Management LLC
4.056 %
2,188,535 4.056 % 122 M $
1,987,744 3.684 % 111 M $
Vanguard Fiduciary Trust Co.
3.281 %
1,770,507 3.281 % 99 M $
AllianceBernstein LP
2.861 %
1,543,628 2.861 % 86 M $
Ameriprise Trust Co.
2.352 %
1,268,872 2.352 % 71 M $
Dimensional Fund Advisors LP
2.302 %
1,241,985 2.302 % 69 M $

Company contact information

LivaNova Plc

20 Eastbourne Terrace

W2 6LG, London

+44 20 3325 0660

http://www.livanova.com
address LivaNova PLC(LIVN)

Group companies

NameCategory and Sector
Medical Specialties
Miscellaneous Commercial Services
Medical Specialties